Oral Dronabinol-HIV

PHASE1RecruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2027

Conditions

HIV

Interventions

DRUG

Dronabinol Capsules

Two 10 mg Dronabinol capsules will be administered orally, for a total of 20mg, on test day.

Trial Locations (1)

RECRUITING

Connecticut Mental Health Center, New Haven

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER